Anti-inflammatory and healing medicine based on laminarin sulphate
AssigneeLaboratoires Goemar S.A.
InventorsJean-Claude Yvin, Susanne Alban, Gerhard Franz
Life of this patent
Estimating the term…
Abstract
The invention concerns the use for preparing a medicine for treating inflammatory diseases induced by non-specific inflammatory responses, that is antigen-independent, of a laminarin sulphate, having a degree of sulphation not less than 1.9 and preferably between 2 and 2.5 degree of polymerization identical to that of the natural molecule, that is 20 to 30.
Claims12
A method for the treatment of non-specific inflammatory disease in a patient comprising administering to the patient in need thereof a composition comprising laminarin sulfate, wherein the laminarin sulfate is sulfated to a level of at least 1.9 and the laminarin sulfate is polymerized to a degree of about 20 to about 30.
A method for the treatment of non-specific inflammatory disease in a patient comprising administering to the patient in need thereof a composition comprising laminarin sulfate, wherein the laminarin sulfate is sulfated to a level of a least 1.9 and the laminarin sulfate is polymerized to a degree of about 20 to about 30, wherein the composition is administered orally in a tablet, syrup, drinkable solution, drinkable suspension, capsule, hard capsule or sachet.
Dependencies are inferred from the claim text.